Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effect of Finishing Clear Aligner Marginal Termination Design (Supragingival vs Juxtagingival) on Aligner Color Stability After 14 Days of Wear: A Split-Mouth Study (SPECTRO-ALIGN)

Colorimetric Stability of Finishing Clear Aligners According to Marginal Termination Design (Supragingival Versus Juxtagingival) After 14 Days of Intraoral Wear During Orthodontic Treatment: A Prospective Split-Mouth Study

  • The goal of this clinical study is to learn whether the gumline edge design of a finishing orthodontic clear aligner affects how much the aligner's color changes after 14 days of wear.
  • The main question is: does a supragingival edge design - a straight edge covering about 2 mm of gum tissue - lead to a different amount of color change in the aligner compared with a juxtagingival edge design that follows the gumline exactly, after 14 days of wear?
  • Each participant wears finishing clear aligners with both edge designs at the same time - one design on the upper jaw and the other on the lower jaw - and serves as their own comparison (split-mouth). This within-person approach removes differences between individuals in oral hygiene, diet, and saliva.
  • The aligner's color over six selected teeth (three upper, three lower) is measured with a dental spectrophotometer (VITA Easyshade V) at placement (day 0) and after 14 days. Each measurement is repeated three times under standardized optical conditions. The amount of color change is expressed as a color-difference value (ΔE).
  • The study hypothesis is that marginal termination design (supragingival versus juxtagingival) is associated with a difference in the 14-day colorimetric change (ΔE00) of the finishing aligner.
  • The study is carried out during the finishing (refinement) stage of orthodontic treatment, when only small residual tooth movements remain, so that color changes can be attributed to wear and edge design rather than to tooth movement.

Panoramica dello studio

Stato

Non ancora reclutamento

Descrizione dettagliata

  • BACKGROUND AND RATIONALE
  • Two trimming-line (edge) designs are commonly used during the finishing (refinement) stage of clear aligner therapy. The supragingival design uses a straight edge positioned approximately 2 mm apical to the free gingival margin, covering approximately 2 mm of gingival tissue. The juxtagingival festooned design follows the natural scalloped contour of the free gingival margin, without covering gingival tissue. Color stability of the aligner during wear is relevant to esthetics and patient acceptance. Whether marginal termination design influences the colorimetric stability of the aligner during wear has not been investigated.
  • STUDY DESIGN
  • This is a prospective, within-person (split-mouth) interventional study. Each participant receives both designs simultaneously: the supragingival design on one dental arch and the juxtagingival festooned design on the contralateral arch. The split-mouth design controls for inter-individual variation in oral hygiene, diet, and salivary composition. The aligner material (CA Pro tri-layer, SCHEU-DENTAL GmbH, Iserlohn, Germany; CE-marked thermoplastic) is identical for both designs; only the marginal termination geometry differs.
  • ALLOCATION RULE (NON-RANDOMIZED)
  • Allocation follows a pre-specified hierarchical rule documented prior to enrollment. Primary criterion: the dental arch with the greater magnitude of planned dental intrusion (mm, from the digital treatment setup) receives the supragingival design. Tiebreaker (equal or zero planned intrusion on both arches): a pre-specified systematic alternating sequence in enrollment order. Planned intrusion magnitude per arch is recorded as a covariate.
  • TARGET TEETH AND MEASUREMENT
  • Colorimetric measurements of the aligner are performed extraorally at six target-tooth positions per participant: three maxillary (1.4, 1.1, 2.3) and three mandibular (4.3, 3.1, 3.4). Measurements are obtained with a dental spectrophotometer (VITA Easyshade V) operated in Custom Color mode, which simultaneously displays the CIE L, a, and b color coordinates. To ensure reproducibility, the aligner is measured under standardized optical conditions using a standardized optical substrate and a fixed positioning reference (methodological details reported separately). Each target position is measured in triplicate at each visit.
  • VISITS
  • Measurements are obtained at T0 (day 0, at placement of the finishing aligner) and T1 (day 14 ± 2 of wear), yielding 36 L, a, b measurements per participant (6 positions × 3 repetitions × 2 visits).
  • OUTCOME
  • The primary outcome is the colorimetric change (ΔE00, CIEDE2000) of the aligner between T0 and T1, computed per dental arch from the measured L, a, b coordinates, compared between the supragingival-design arch and the juxtagingival-design arch. The CIELAB ΔEab value is reported descriptively for comparability with prior literature.
  • STUDY CONTEXT
  • The study is conducted during the finishing (refinement) stage, when only small residual tooth movements remain, so that observed color changes can be attributed to wear and marginal termination design rather than to substantial tooth movement.
  • RELATIONSHIP TO COMPANION STUDY
  • A subset of participants may be concurrently enrolled in the companion study PATHO-ALIGN (ClinicalTrials.gov NCT07533058), a split-mouth study of finishing-aligner marginal termination design and subgingival periodontal microbiota conducted by the same investigator at the same sites. Co-enrolled participants wear the same finishing clear aligners with the same arch-level marginal-design allocation in both studies; the present study adds only a non-invasive, extraoral colorimetric assessment of the aligners and does not interfere with the companion study. The two studies have distinct outcomes.
  • STATISTICAL ANALYSIS
  • Primary confirmatory analysis: The confirmatory endpoint is the arch-level aligner color change (ΔE00) between T0 and T1. The supragingival-design arch and the juxtagingival-design arch are compared within participants using a paired test (two-sided, alpha = 0.05). Normality of the paired differences is assessed (Shapiro-Wilk); a paired t-test is used if the assumption holds, otherwise the Wilcoxon signed-rank test. A single confirmatory comparison is pre-specified, controlling the type I error rate without multiplicity correction.
  • Adjusted analysis: A linear mixed-effects model is fitted to arch-level ΔE00, with marginal termination design (supragingival vs juxtagingival), dental arch (maxillary vs mandibular), planned intrusion magnitude per arch, and self-reported daily wear time as fixed effects, and a participant-level random intercept to account for the paired (split-mouth) structure. Including dental arch as a covariate separates a potential arch-level effect from the design effect.
  • Secondary analyses (descriptive): Component color changes (ΔL, Δa, Δb) per arch between T0 and T1; overall aligner color change across all target positions (ΔE00 and ΔEab); and the proportion of arch-level changes exceeding the Paravina (2015) perceptibility (ΔE00 = 0.8) and acceptability (ΔE00 = 1.8) thresholds.
  • Measurement reliability: Intra-position reproducibility across the three repeated measurements is quantified using the intraclass correlation coefficient (ICC).
  • Missing data and quality control: Repeated measurements failing pre-specified inter-repetition agreement criteria are excluded, and the mean of the remaining repetitions is used; analyses use available per-protocol data.
  • SAMPLE SIZE JUSTIFICATION
  • Sample size was determined for a paired within-subject (split-mouth) comparison of arch-level aligner color change (ΔE00). In the absence of prior data specific to marginal termination design effects on aligner color, parameters were selected conservatively: a minimum meaningful between-arch difference of ΔE00 = 0.8 (50:50% perceptibility threshold; Paravina 2015), an assumed standard deviation of paired differences of approximately 0.9 (derived from an assumed arch-level standard deviation with an intra-subject correlation rho = 0.4), and a two-sided alpha = 0.05 (paired test). Under these assumptions, 50 participants provide power exceeding 90% to detect the specified difference and remain adequately powered (approximately 85%) for smaller between-arch differences (ΔE00 ≈ 0.4). The enrolled sample (50 participants; 100 aligners, two per participant) also serves to estimate within-subject colorimetric variability to refine power assumptions for subsequent confirmatory studies.

Tipo di studio

Interventistico

Iscrizione (Stimato)

50

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Sibiu County
      • Sibiu, Sibiu County, Romania, 550118
        • Aorys Clinic
        • Contatto:
        • Investigatore principale:
          • EMILIA (PRODEA) RUSU, DDS, Specialist Orthodontist

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Adolescent and adult patients (age 15 years or older at enrollment)
  • Undergoing a finishing (refinement) stage of clear aligner therapy, with only small residual tooth movements remaining, including both patients completing active orthodontic treatment and patients with prior orthodontic treatment who require additional refinement (e.g., minor relapse or loss of retention)
  • Adherence to the prescribed oral hygiene instructions
  • Written informed consent; for participants aged 15-17 years, written consent from a parent or legal guardian

Exclusion Criteria:

  • Deficient oral hygiene
  • Excessive consumption of intensely staining beverages (coffee, tea, red wine, colored carbonated drinks)
  • Systemic conditions or medications that may affect salivary secretion or tooth color
  • Non-compliance with the aligner / orthodontic appliance wear protocol

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: Non randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Supragingival Trimming-Line Design
Finishing clear aligner with a straight trimming-line positioned approximately 2 mm apical to the free gingival margin, covering approximately 2 mm of gingival tissue. Assigned to the arch with greater planned intrusion; if equal or zero on both arches, assigned by pre-specified systematic alternation in enrollment order.
Finishing clear aligner fabricated from CA Pro tri-layer thermoplastic (SCHEU-DENTAL GmbH, Iserlohn, Germany; CE-marked), fabricated by SC APARAT DENTAR SRL, Sibiu, Romania. Each participant receives aligners with both trimming-line designs simultaneously - supragingival on one arch and juxtagingival festooned on the contralateral arch. Material and thickness are identical for both designs; only trimming-line geometry differs. (Cross-referenced to both arms.)
Comparatore attivo: Juxtagingival Festooned Trimming-Line Design
Finishing clear aligner with a festooned trimming-line following the natural scalloped contour of the free gingival margin, terminating at the gingival margin without covering gingival tissue. Assigned to the contralateral arch.
Finishing clear aligner fabricated from CA Pro tri-layer thermoplastic (SCHEU-DENTAL GmbH, Iserlohn, Germany; CE-marked), fabricated by SC APARAT DENTAR SRL, Sibiu, Romania. Each participant receives aligners with both trimming-line designs simultaneously - supragingival on one arch and juxtagingival festooned on the contralateral arch. Material and thickness are identical for both designs; only trimming-line geometry differs. (Cross-referenced to both arms.)

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Aligner Color Change (ΔE00) After 14 Days of Wear
Lasso di tempo: Day 0 and day 14
Mean color change (ΔE00, CIEDE2000) of the finishing aligner between day 0 and day 14, per dental arch, computed from CIE L*, a*, b* coordinates averaged over three target positions measured in triplicate. The supragingival-design arch and the juxtagingival-design arch are compared within each participant (paired split-mouth).
Day 0 and day 14

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Component Color Changes (ΔL*, Δa*, Δb*)
Lasso di tempo: Day 0 and day 14
Mean changes in the individual CIE coordinates per arch between day 0 and day 14, characterizing the direction of color change (lightness; red-green; yellow-blue axes).
Day 0 and day 14
Overall Aligner Color Change (ΔE00 and ΔE*ab, pooled)
Lasso di tempo: Day 0 and day 14
Color change of the finishing aligner across all target positions regardless of marginal termination design, reported as ΔE00 (CIEDE2000) and, for comparability with prior literature, ΔE*ab (CIELAB), characterizing overall colorimetric stability during wear.
Day 0 and day 14

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Proportion of Measurements Exceeding Perceptibility / Acceptability Thresholds
Lasso di tempo: Day 0 and day 14
Proportion of arch-level color changes exceeding the 50:50% perceptibility (ΔE00 = 0.8) and acceptability (ΔE00 = 1.8) thresholds (Paravina 2015). Interpreted descriptively; these thresholds were established for permanent restorations compared with adjacent teeth and are used here only as a reference standard, not as a clinical failure criterion for a temporary 14-day aligner.
Day 0 and day 14

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Cattedra di studio: LUMINITA LAZAR, PhD, Professor, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 38 Gheorghe Marinescu Street, 540139 Targu Mures, Romania
  • Investigatore principale: EMILIA (PRODEA) RUSU, DDS, Specialist Orthodontist, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 38 Gheorghe Marinescu Street, 540139 Targu Mures, Romania

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

15 giugno 2026

Completamento primario (Stimato)

15 agosto 2026

Completamento dello studio (Stimato)

15 agosto 2026

Date di iscrizione allo studio

Primo inviato

31 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

31 maggio 2026

Primo Inserito (Effettivo)

5 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

5 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

31 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

Descrizione del piano IPD

De-identified individual participant data (participant codes, arch-level color change values ΔE00 and ΔE*ab, component changes ΔL*/Δa*/Δb* and baseline covariates) will be made available as a CSV or Excel file upon reasonable request to the corresponding author following publication of study results.

Periodo di condivisione IPD

Beginning 6 months after publication of primary study results.

Criteri di accesso alla condivisione IPD

Upon reasonable request to the corresponding author (PI); requests reviewed within 30 days.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • LINFA

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi